tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Lepu Biopharma Co. Ltd. Class H (2157) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$5.82
HK$9.10B
43.70%
Ascletis Pharma, Inc.
HK$9.62
HK$8.65B
968.89%
0 Buy
0 Hold
0 Sell
Hold
Keymed Biosciences, Inc.
HK$45.70
HK$12.83B
28.90%
0 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$23.15
HK$13.90B
317.87%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$21.60
HK$8.57B
238.35
193.33%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$12.20
HK$9.75B
-12.98%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.82
1.87
47.34%
HK:1672
Ascletis Pharma, Inc.
9.62
8.76
1018.60%
HK:2162
Keymed Biosciences, Inc.
44.60
10.00
28.90%
HK:2171
CARsgen Therapeutics Holdings Ltd.
23.15
18.28
375.36%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
22.00
14.51
193.72%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
12.60
-1.40
-10.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis